Abstract Chimeric antigen receptor (CAR) T cells are engineered cells used in cancer therapy and are studied to treat infectious diseases. Trafficking and persistence of CAR T cells is an important requirement for efficacy to target cancer. Here, we describe a CAR RNA FISH histo-cytometry platform combined with a random reaction seed image analysis algorithm to quantitate spatial distribution and in vivo functional activity of a CAR T cell population at a single cell resolution for preclinical models. In situ, CAR T cell exhibited a heterogenous effector gene expression and this was related to the distance from tumor cells, allowing a quantitative assessment of the potential in vivo effectiveness. The platform offers the potential to study ...
The expression of synthetic receptors in primary T cells enables the programming of user-defined res...
Jurkat T cells have been used as a model cell in CAR-T engineering for cancer research. T cells func...
The use of T-cells expressing Chimeric Antigen Receptors (CARs) offers new opportunities for cancer ...
Chimeric antigen receptor (CAR) T cell performance against solid tumors in mouse models and clinical...
Chimeric antigen receptor (CAR) T cell performance against solid tumors in mouse models and clinical...
Chimeric antigen receptors (CARs) consist of an antigen-binding region fused to intracellular signal...
Genetic engineering of cellular function holds much promise for the treatment of a variety of diseas...
Adoptive cell transfer of Chimeric Antigen Receptor (CAR)-T cells showed promising results in patien...
Genetic engineering of cellular function holds much promise for the treatment of a variety of diseas...
Chimeric antigen receptor (CAR) T-cell therapy has been successful in treating liquid tumors but has...
BackgroundT cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
Abstract Intratumor heterogeneity of tumor clones and an immunosuppressive microenvironment in cance...
Chimeric antigen receptors (CAR) are genetically engineered receptors that can recognise specific an...
Aims: Chimeric Antigen Receptor (CAR) T-cell is a breakthrough in cancer immunotherapy. The primary ...
The expression of synthetic receptors in primary T cells enables the programming of user-defined res...
Jurkat T cells have been used as a model cell in CAR-T engineering for cancer research. T cells func...
The use of T-cells expressing Chimeric Antigen Receptors (CARs) offers new opportunities for cancer ...
Chimeric antigen receptor (CAR) T cell performance against solid tumors in mouse models and clinical...
Chimeric antigen receptor (CAR) T cell performance against solid tumors in mouse models and clinical...
Chimeric antigen receptors (CARs) consist of an antigen-binding region fused to intracellular signal...
Genetic engineering of cellular function holds much promise for the treatment of a variety of diseas...
Adoptive cell transfer of Chimeric Antigen Receptor (CAR)-T cells showed promising results in patien...
Genetic engineering of cellular function holds much promise for the treatment of a variety of diseas...
Chimeric antigen receptor (CAR) T-cell therapy has been successful in treating liquid tumors but has...
BackgroundT cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
Abstract Intratumor heterogeneity of tumor clones and an immunosuppressive microenvironment in cance...
Chimeric antigen receptors (CAR) are genetically engineered receptors that can recognise specific an...
Aims: Chimeric Antigen Receptor (CAR) T-cell is a breakthrough in cancer immunotherapy. The primary ...
The expression of synthetic receptors in primary T cells enables the programming of user-defined res...
Jurkat T cells have been used as a model cell in CAR-T engineering for cancer research. T cells func...
The use of T-cells expressing Chimeric Antigen Receptors (CARs) offers new opportunities for cancer ...